TMCI:NASDAQ
Treace Medical Concepts, Inc
4,45 $
arrow_upward
+1,37%(+0,060) 1D
5 հոկ, 12:25:56 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,40 $
High
4,45 $
Low
4,24 $
Mkt. cap
289,40 մլն
Avg. vol.
238,13 հզր
Volume
58,18 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
Open
4,40 $
High
4,45 $
Low
4,24 $
Mkt. cap
289,40 մլն
Avg. vol.
238,13 հզր
Volume
58,18 հզր
52-wk high
7,08 $
52-wk low
1,17 $
EPS
-0,93 $
Beta
1,48
Shares outstanding
65,04 մլն
No. of employees
450
News stories
From web sources and news partners
Investing News Network
·
1 ժամ առաջ
Estée Lauder at NYSE for Breast Cancer Awareness Month: NYSE Content Update
Benzinga
·
1 ժամ առաջ
Greenland Mines (NASDAQ: GRML) Completes 2026 Skaergaard Field Program
KTVN
·
20 րոպե առաջ
US stocks are rising near their records, with the Nasdaq composite on track for an all-time high
Yahoo Finance
·
1 ժամ առաջ
Prediction: This Lesser-Known Growth ETF Will Crush the S&P 500 Over the Next 20 Years
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc